Our Firm is representing a number of women who were allegedly harmed by transvaginal mesh manufactured by C.R. Bard Inc.
New York, NY (PRWEB) January 03, 2015
The New Jersey litigation established for C.R. Bard transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) is gearing up for a status conference scheduled to take place in January, Bernstein Liebhard LLP reports.
According to court documents, the meeting will convene on January 6, 2015 at 10:30 a.m. in New Jersey’s Bergen County Superior Court. Parties involved in the proceeding will likely discuss issues related to lawsuits involving transvaginal mesh manufactured by C.R. Bard Inc., which allege mesh erosion, chronic pain, pain during sexual intercourse and other injuries. Plaintiffs in these cases accuse the company of failing to adequately warn about these risks in their marketing of its pelvic implants. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)
“Our Firm is representing a number of women who were allegedly harmed by transvaginal mesh manufactured by C.R. Bard Inc. We are pleased to see continued progress in the New Jersey litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices including transvaginal mesh. The Firm is currently offering free and confidential case evaluations to women who may have sustained injuries resulting from implantation of mesh manufactured by C.R. Bard Inc., Boston Scientific Corp., American Medical Systems Inc. and the Johnson & Johnson subsidiary, Ethicon Inc.
Transvaginal Mesh Lawsuits
All the C.R. Bard lawsuits in New Jersey were similarly filed after a 2008 health alert from the U.S. Food and Drug Administration (FDA) that women implanted with the devices may be susceptible to vaginal mesh complications. The alert categorized the risk for these problems as “rare,” a stance that was later augmented to “not rare,” as per a notice issued in July 2011. At the time, 3,000 adverse event reports had been received by women who claimed to have been injured by the devices over a period of three years. In April 2014, the FDA proposed new regulations that would reclassify transvaginal mesh implants as “high risk,” which would make them subject to greater regulatory oversight.
Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, is actively serving as Co-Liaison Counsel for the C.R. Bard litigation underway in New Jersey’s Bergen County; the same location as a separate proceeding that involves claims against Johnson & Johnson’s Ethicon unit. Mr. Grand also served on the plaintiff’s trial team for a hearing that concluded in March 2013 with an $11 million damage award to a woman whose injuries were found to be caused by her Gynecare Prolift implant.
In addition to his work with the consolidated mesh proceedings underway in New Jersey, Mr. Grand is also serving as Co-Liaison Counsel in the following seven multidistrict litigations underway in the U.S. District Court, Southern District of West Virginia: In Re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2187; In Re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In Re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327; Coloplast Corp. Pelvic Support Systems Products Liability Litigation - MDL No. 2387; In Re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation - MDL No. 2440; and In Re: Neomedic Pelvic Repair System Products Liability Litigation - MDL No. 2511.
Women who sustained serious complications allegedly resulting from transvaginal mesh may be eligible to receive compensation for lost wages, medical bills, pain and suffering and other injury-related damages. Learn more about filing a transvaginal mesh lawsuit by visiting Bernstein Liebhard LLP’s website, or via the Firm’s Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP